CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,910,555
+$1,872,980 QoQ
Shares Held
394,607
+18.7% QoQ
Ownership
0.586%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 183 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. DNA ranks #155 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in DNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,910,555 | 394,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,037,575 | 332,394 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,977,431 | 358,295 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,009,075 | 343,558 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,729,813 | 331,539 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,328,955 | 233,150 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,295,100 | 233,717 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,763,211 | 216,345 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,232,921 | 6,685,393 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,155,383 | 7,892,572 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,947,602 | 7,661,303 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,427,298 | 7,418,397 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,907,629 | 5,864,317 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,115,260 | 5,349,820 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,984,126 | 4,724,335 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,482,262 | 4,000,725 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,203,884 | 2,606,674 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,086,562 | 2,999,147 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $24,686,508 | 2,970,699 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||